Biomaterial Industry Market Research & Statistics

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
5 votes

Global Biomaterial Industry


The global biomaterials industry was worth close to $38 billion in 2011, according to research from Industry Experts. The market is expected to record close to 15% yearly growth for the ten-year period ending 2017 to reach $84 billion.


Biomaterials are used in the manufacture of medical devices, making them biocompatible. Medical devices are subject to strict regulatory standards. Medical technology development has negatively impacted plastic materials used in medical applications.


Biocompatibility has become key for implant materials, with strict demands regarding mechanical performance.




Key Market Segments


  • The global orthopedic biomaterial industry generated $12 billion in 2010, representing close to 38% of the overall biomaterial market, reports Markets and Markets. Demand is fuelled by an aging population and technological advancements in the biomaterials market. Market growth is expected to reach a yearly rate of close to 13% between 2010 and 2015, which is relatively slow as a result of market maturity.


  • Organic and synthetic orthopedic biomaterial products are used for implant in or around bone fractures. Their function is to encourage healing or make up for declining or absent bone tissue. Biomaterials need to be biocompatible not to result in inflammation or to be rejected by the body. Kalorama Information states that biomaterial products for orthopedic surgery include xenografts, synovial fluid substitutes, autografts, polymers, allografts, bone growth factors and ceramics. Common applications for orthopedic biomaterials include bone cements, fracture fixation plates, bone defect fillers and surface coatings for hip prostheses.


  • The global biocompatible materialsmarket is expected to exceed $63 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by rising life expectancy, an aging population, broader application areas of biomaterials, increased use of biocompatible materials, patient benefits and awareness, and comparatively shorter life cycles of medical device products.


  • Growth in the significant areas of biomaterial application include drug delivery, orthopedic, cardiovascular and neurological. On a yearly basis, 200,000 pacemakers and around 1 million orthopedic devices are implanted in patients worldwide. The industry is witnessing increasing use of natural substances like animal and human tissues in biomaterials for surgical use, driven by developments in tissue processing technologies, particularly in chronic conditions such as organ malfunction or failure. Leading companies operating in the global biocompatible materials industry include Orthovita, Synthes, A.P. Pharma, Integra LifeSciences, SurModics, Angiotech, SaluMedica, Biocoat, Artimplant, Dentsply International, AST Products and Invibio.


  • The world collagen and HA-based (Hyaluronic Acid-based) biomaterials market is expected to exceed $3.5 billion by 2017, according to research from Global Industry Analysts. Market growth will be fuelled by increasing interest in personal healthcare and a global aging population. Growth in the sector would benefit from technological advancements and developments in facial aesthetic dermal implants, bone grafting substance, and tissue engineering.


  • The US dominates the world market for collagen and HA-based biomaterials due to higher personal healthcare awareness and an aging population. The rest of the world constitutes the regional market recording the fastest rate of growth, expected to remain close to 12% through 2017. Hyaluronic Acid-based Biomaterials represent the leading market segment, and viscosupplements represent the largest segment among HA-based biomaterials. Facial aesthetic dermal implants represent the segment expected to record the fastest growth through 2017. Biomaterials demand for the treatment of cataracts, wrinkles and osteoarthritis is being driven by an aging worldwide population.



Market Outlook


The global biomaterials market is expanding due to physical disability among an increasing aging population. According to Markets and Markets, over 20% of the world’s population will be over 60 years of age in 2050, which points to vast potential for the biomaterials market. Issues that will dictate the market’s growth rate include the extensive research necessary for the development of new and higher quality products, pricing and regulations.


Due to the high expense of biomaterial products, performance is of particular importance as it can defend the expense factor. Moving forward, mergers and acquisitions will remain important, with the market witnessing greater collaboration between material suppliers and manufacturing outfits. US state funding of the healthcare sector may also drive the biomaterials market.



Leading Industry Associations offers immediate download access to top market reports & statistics on the Biomaterial Industry from trusted sources.
24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-8 of 8 reports

Fibrinogen Market in the UK

  • August 2014
    11 pages
  • Plasma  

    Blood Supply  


  • United Kingdom  

View report >

The future of the Biomaterials Industry in the US

  • January 2013
  • Biomaterials  

  • United States  

View report >

Biomaterial market shares in China Forecast

  • January 2012
    10 pages
  • Biomaterial  


    Medical Devices  

  • China  


View report >

Hydrogel Market Share in the US

  • July 2011
    11 pages
  • Hydrogel  

  • United States  

View report >

Biomaterial Market Forecast in Brazil

  • January 2011
    3 pages
  • Biomaterial  

  • Brazil  

    South America  

View report >

Hydrogel supply in the US

  • December 2010
    11 pages
  • Hydrogel  

  • United States  

View report >

Fibrinogen Industry

  • March 2010
    8 pages
  • Fibrinogen  

View report >

Biomaterials market trends Forecast

  • January 2010
    2 pages
  • Biomaterials  

View report >

Search in Biomaterial Industry (8 reports)
Topics under Biomaterial

Parent industry:  Biotechnology

Related industries: Biological Therapy, Biopharmaceutical, Genetically Modified Organism, GMO, Genomics

About 100 reports

Purchase Reports From Reputable Market Research Publishers
(From € 44 - € 5 596)

U.S. Orthopedic Biomaterials Market

U.S. Orthopedic Biomaterials Market

  • € 5 596
  • Industry report
  • January 2015
  • by iData Research, Inc.

The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential ...

Global Markets For Implantable Biomaterials

January 2015 € 5 320

World Collagen And Ha-based Biomaterials Industry

January 2015 € 3 960

2015 Deep Market Research Report On Global Dental Bioma ...

January 2015 € 2 080

2015 Deep Research Report On Global Dental Biomaterial ...

January 2015 € 2 080

Global Cosmeceuticals Market 2015-2019

December 2014 € 2 000

Medisse Bv - Product Pipeline Analysis, 2014 Update

December 2014 € 600

Freedonia Focus On Biocompatible Materials: United Stat ...

December 2014 € 480

Freedonia Focus On Biocompatible Metals: United States

December 2014 € 480

Aap Implantate Ag (symbol:aaq) Swot Analysis, Strategy, ...

January 2015 € 240

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.